Melak Gedamu Beyene

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Prognostic Factors

Ejection Fraction

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Pineal Yitbarek Fisseha, Assefa Mulu Baye, Melak Gedamu Beyene, Eyasu Mekonnen Eshetu
Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Pineal Yitbarek Fisseha, Assefa Mulu Baye, Melak Gedamu Beyene, Eyasu Mekonnen Eshetu
Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Hawaryaw Mathewos Hadero, Melak Gedamu Beyene, Assefa Mulu Baye, Eskinder Ayalew Sisay
Outcome of antiemetic prophylaxis among pediatric cancer patients receiving moderate to highly emetogenic chemotherapy at pediatric hemato-oncology ward of Tikur Anbessa specialized hospital: A prospective observational study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)